SCHEMBL28518079

SCHEMBL28518079

CC(C)(C)OC(=O)N1CCN(c2nc3c[nH]cc3nc2NS(C)(=O)=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.42
GBA1 P04062 2/20 0.42
TLR9 Q9NR96 1/20 0.41
ACHE P22303 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
MAP4K4 O95819 1/20 0.41
GPR119 Q8TDV5 5/20 0.40
NAMPT P43490 1/20 0.40
CKS1B P61024 1/20 0.40
SKP1 P63208 1/20 0.40
SKP2 Q13309 1/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
STS P08842 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL189681 0.79 MAPT (0.61) KITGBA1ACHEOPRM1OPRD1
SCHEMBL15566743 0.73 GPR6 (0.59) GBA1OPRM1OPRD1OGFRL1
SCHEMBL24970264 0.72 MEN1 (0.47) KITGPR119DDB1CRBNSTS
SCHEMBL30903380 0.72 MEN1 (0.47) KITGPR119DDB1CRBNSTS
SCHEMBL30819461 0.72 GBA1 (0.56) KITGBA1ACHEOPRM1OPRD1
SCHEMBL24951551 0.72 GBA1 (0.56) KITGBA1ACHEOPRM1OPRD1
SCHEMBL4513123 0.71 NPY5R (0.48) GPR119NAMPTCKS1BSKP1SKP2
SCHEMBL30261848 0.70 DDB1 (0.62) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL28956351 0.70 DDB1 (0.62) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL16818116 0.70 GPR6 (0.52) KITGBA1ACHEOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112313228-A Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2021-02-02 CN disclosed